DPI-221 is an
opioiddrug that is used in scientific research. It is a highly selective
agonist for the
δ-opioidreceptor, which produces fewer
convulsions than most drugs from this family.[1]
References
^Holt JD, Watson MJ, Chang JP, O'Neill SJ, Wei K, Pendergast W, et al. (November 2005). "DPI-221 [4-((alpha-s)-alpha-((2s,5r)-2,5-dimethyl-4-(3-fluorobenzyl)-1-piperazinyl)benzyl)-N,N-diethylbenzamide]: a novel nonpeptide delta receptor agonist producing increased micturition interval in normal rats". The Journal of Pharmacology and Experimental Therapeutics. 315 (2): 601–8.
doi:
10.1124/jpet.105.090498.
PMID16020629.
S2CID97486165.